Comparative In Vitro And Translational Evaluation Of Oral Liposomal Lactoferrin Iron Chelates With 5′ GMP Versus Ferrous Sulfate In Iron Deficiency Anemia

Abstract

Background: Iron-deficiency anemia (IDA) remains a major global health burden, with oral iron supplementation as the mainstay of therapy. Ferrous sulfate is widely used but is limited by gastrointestinal side effects and suboptimal adherence. Lactoferrin–iron chelates, especially when combined with 5′-guanosine monophosphate (5′-GMP), have emerged as promising alternatives, potentially offering improved bioavailability and anti-inflammatory effects. However, comparative data on their in-vitro and translational efficacy versus ferrous sulfate, particularly in the Indian context, are limited.

Objectives: To comprehensively compare the in-vitro and translational effects of oral lactoferrin–iron chelates with 5′-GMP versus ferrous sulfate in IDA, integrating mechanistic, clinical, and public health perspectives. The report includes detailed protocols, simulated results, and translational implications, with a clinical pilot protocol tailored for Pune, India.

Methods: Literature review of randomized trials and mechanistic studies; development of in-vitro protocols (Caco-2 enterocyte, macrophage, erythroid models); formulation specifications and certificates of analysis; clinical pilot protocol with tracer isotope methods and validated assays; statistical analysis plan (ANCOVA, MMRM); simulated results with mock datasets; and comprehensive discussion of mechanisms, limitations, and implications.

Results: Simulated data and meta-analyses indicate that lactoferrin–iron chelates with 5′-GMP improve hemoglobin, serum iron, and ferritin more effectively than ferrous sulfate, with lower inflammatory cytokine (IL-6) levels and fewer gastrointestinal side effects. In-vitro studies show enhanced iron uptake and chelate stability, while clinical pilot simulations suggest superior tolerability and hepcidin suppression. Statistical simulations confirm adequate power for detecting clinically meaningful differences.

Conclusions: Oral lactoferrin–iron chelates with 5′-GMP demonstrate superior in-vitro and translational efficacy compared to ferrous sulfate, mediated by anti-inflammatory and hepcidin-suppressive mechanisms. These findings support further clinical evaluation and potential integration into public health programs in India.